Reinforcing effects of stimulants in humans: Sensitivity of progressive-ratio schedules.
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Drug self-administration methodologies have been developed for use in humans to model naturalistic stimulant drug-taking behaviors. These methodologies use a number of schedules of reinforcement, including progressive-ratio schedules. As the name implies, in a progressive-ratio schedule, the response requirement for each subsequent delivery of drug increases, and the primary outcome variable is often the break point (i.e., the last ratio completed to receive a drug delivery). These schedules have been used in a number of human laboratory studies evaluating the reinforcing effects of stimulants. The results of these studies have demonstrated that progressive-ratio schedules are sensitive to manipulation of a pharmacological variable, dose, and to nonpharmacological variables contributing to stimulant drug effects. In addition, findings with progressive-ratio schedules are largely concordant with clinical findings, suggesting that drug self-administration under these schedules has predictive validity in terms of drug abuse and dependence. Future research is necessary, however, to understand better how pharmacological factors like route of administration, onset of effects, and pretreatment influence the reinforcing effects of stimulants under progressive-ratio schedules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391
Medical Use, Illicit Use and Diversion of Prescription Stimulant Medication
McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399827 · Cited by 305
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270 · cited 3×
“It should be noted, however, that in humans the reinforcing effects of stimulant drugs are notoriously difficult to alter with pharmacological pretreatment regardless of schedule of reinforcement (Haney et al., 2006; Haney & Spealman, 2008).”
BackgroundMethodDextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243 · cited 2×
“ently necessary to decrease stimulant use (Grabowski et al., 2001).”
BackgroundComer, S. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1996) · Psychopharmacology · doi:10.1007/bf02805973 · Cited by 26
Cited by
Scale for the Assessment of Negative Symptoms
Andreasen, N. C. (2014) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,866
Animal models of psychiatric disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 336
Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0948 · Cited by 186
Translational assessment of reward and motivational deficits in psychiatric disorders
Der-Avakian, A., Barnes, S. A., Markou, A., & Pizzagalli, D. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5004 · Cited by 122
Cory-Slechta, D. A., Allen, J. L., Conrad, K., Marvin, E., & Sobolewski, M. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2017.12.003 · Cited by 63
Metadata
- Authors
- Stoops, W. W.
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 2008
- Volume
- 16
- Issue
- 6
- Pages
- 503-512
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- OpenAlex
- W2030492805
- Cited by
- 54
- References
- 5
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.